Innoviva Inc reports results for the quarter ended June 30 - Earnings Summary

• Innoviva Inc INVA.OQ reported quarterly adjusted earnings of 77 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -55 cents. The mean expectation of three analysts for the quarter was for earnings of 50 cents per share. Wall Street expected results to range from 43 cents to 57 cents per share.

• Revenue rose 0.4% to $100.28 million from a year ago; analysts expected $92.04 million.

• Innoviva Inc's reported EPS for the quarter was 77 cents​.

• The company reported quarterly net income of $63.69 million.

• Innoviva Inc shares had fallen by 8.2% this quarter and gained 6.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 16.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Innoviva Inc is $40.00, about 53.9% above its last closing price of $18.44

This summary was machine generated from LSEG data August 6 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)